NCT01327612: A reported trial by Amgen
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01327612 |
|---|---|
| Title | A Phase 2 Open Label Extension Study of Conatumumab and AMG 479 |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 3, 2011 |
| Completion date | Feb. 5, 2020 |
| Required reporting date | Feb. 4, 2021, midnight |
| Actual reporting date | Feb. 3, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |